Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ASRT
ASRT logo

ASRT Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Assertio Holdings Inc (ASRT) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
23.440
1 Day change
0.04%
52 Week Range
23.470
Analysis Updated At
2026/06/05
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Assertio Holdings Inc (ASRT) is not a good buy right now for a beginner long-term investor with $50,000-$100,000 available. The available data does not show a confirmed bullish price trend, there are no proprietary buy signals today, and analyst views are mixed-to-neutral rather than strongly positive. Based on the current information, the best call is to hold off rather than buy immediately.

Technical Analysis

Technical trend data could not be fetched, so there is no reliable confirmation of a current uptrend, breakout, or support-based entry. The market price is shown as moving in line with the S&P 500 at 0%, which suggests no relative momentum advantage today. With no trend data and no Intellectia buy signal, the chart picture does not support an aggressive immediate entry.

Positive Catalysts

  • The main positive catalyst is the higher price target from H.C. Wainwright to $21.80, reflecting improved takeover-related expectations tied to Garda Therapeutics' increased offer. That suggests some upside optionality if acquisition dynamics continue to improve.

Neutral/Negative Catalysts

  • There is no AI Stock Picker signal today and no recent SwingMax signal. Stock trend data is unavailable, which removes a key confirmation tool. The most recent analyst action before the target increase was a downgrade from Lake Street to Hold, showing that sentiment is not uniformly bullish. No recent congress trading data is available, and no notable politician or influential figure buying/selling activity was provided.

Financial Performance

No financial data was provided, so the latest quarter season and growth trends cannot be assessed from the supplied information.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analyst sentiment is mixed. On 2026-05-05, H.C. Wainwright raised the price target to $21.80 from $18 and kept a Neutral rating, while on 2026-04-09 Lake Street downgraded the stock to Hold from Buy with an $18 target. Wall Street appears cautious overall: there is some upside target revision, but the ratings are not strongly bullish and do not suggest a clear long-term buy consensus.

Wall Street analysts forecast ASRT stock price to rise
2 Analyst Rating
Wall Street analysts forecast ASRT stock price to rise
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 23.430
sliders
Low
35
Averages
40
High
45
Current: 23.430
sliders
Low
35
Averages
40
High
45
H.C. Wainwright
Raghuram Selvaraju
Neutral
maintain
$18
AI Analysis
2026-05-05
Reason
H.C. Wainwright
Raghuram Selvaraju
Price Target
$18
AI Analysis
2026-05-05
maintain
Neutral
Reason
H.C. Wainwright analyst Raghuram Selvaraju raised the firm's price target on Assertio to $21.80 from $18 and keeps a Neutral rating on the shares. The firm cites Garda Therapeutics' increased takeout offer for the target boost.
Lake Street
Buy
to
Hold
downgrade
$18
2026-04-09
Reason
Lake Street
Price Target
$18
2026-04-09
downgrade
Buy
to
Hold
Reason
Lake Street downgraded Assertio to Hold from Buy with an $18 price target.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for ASRT
Unlock Now

People Also Watch